Arkolith/Insider Trading/SGMT/Form 4

Happel David

President & CEO, DirectorSagimet Biosciences Inc. (SGMT) · full profile →Form 4 · filed Mar 28, 2024
Net Buying
Open-Market Buys
$64K
Open-Market Sells
$0
Net Open-Market Flow
$64K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2024Buy(P)12K$5.27$64K639K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-040517) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML